For the Inventor, By the Inventor

Enter assignee name

Houston, TX, United States of America

Texas Biotechnology Corporation

USPTO Granted Patents = 37

Trademarks = 1

Forward Citations = 698

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Chengde Wu (21 out of 31 patents)

Timothy P Kogan (20 out of 29 patents)

Bore G Raju (16 out of 19 patents)

4. Erik Joel Verner (15 out of 19 patents)

5. Ming Fai Chan (14 out of 39 patents)

6. Vitukudi Narayanaiyengar Balaji (12 out of 19 patents)

7. Adam Kois (11 out of 21 patents)

8. Rosario Silvestre Castillo (11 out of 13 patents)

9. Karin M Keller (9 out of 9 patents)

10. Venkatachalapathi Yalamoori (8 out of 9 patents)

11. Natalie Blok (7 out of 8 patents)

12. Ian Leslie Scott (7 out of 15 patents)

13. Jamal M Kassir (5 out of 8 patents)

14. Pamela J Beck (5 out of 5 patents)

15. Robert V Market (4 out of 17 patents)

37 patents: Sort by Forward Citations

1. 6723711 - Propanoic acid derivatives that inhibit the binding of integrins to their receptors (2004-04-20),

2. 6713604 - Process to inhibit binding of the integrin &agr;4&bgr;1 , to VCAM-1 fibronectin and cyclic peptides thereof (2004-03-30),

3. 6683103 - Sulfonamides for treatment of endothelin-mediated disorders (2004-01-27),

4. 6632829 - Sulfonamides and derivatives thereof that modulate the activity of endothelin (2003-10-14),

5. 6545014 - Method of treating glaucoma (2003-04-08),

6. 6541498 - Benzenesulfonamides and the use thereof to modulate the activity of endothelin (2003-04-01),

7. 6458805 - Formulation of sulfonamides for treatment of endothelin-mediated disorders (2002-10-01),

8. 6432994 - Sulfonamides for treatment of endothelin-mediated disorders (2002-08-13),

9. 6420567 - N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelin (2002-07-16),

10. 6384261 - Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin (2002-05-07),

11. 6376523 - Benzenesulfonamides and the use thereof to modulate the activity of endothelin (2002-04-23),

12. 6342610 - N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin (2002-01-29),

13. 6331637 - N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin (2001-12-18),

14. 6329387 - Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin (2001-12-11),

15. 6265428 - Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin (2001-07-24),

Texas Biotechnology Corporation is a leading biotech company based in Texas, specializing in innovative research and development of biotechnological solutions. With a team of dedicated scientists and experts, we aim to improve human health by creating breakthrough products and technologies. We focus on the discovery and development of novel therapeutics, diagnostics, and tools for precision medicine. At Texas Biotech, we strive to make a positive impact on society through our cutting-edge biotech advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

37 Patents

#145 in Houston, TX

#508 in Texas

#8,949 in US

#17,726 in the World

Houston, TX, United States of America

Texas Biotechnology Corporation

Forward Citations = 698

37 inventors:

Chengde Wu (21 out of 31 patents)

Timothy P Kogan (20 out of 29 patents)

Bore G Raju (16 out of 19 patents)

4. Erik Joel Verner (15 out of 19 patents)

5. Ming Fai Chan (14 out of 39 patents)

Please report any incorrect information to support@idiyas.com

Loading…